These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4177677)

  • 21. [A gradual method for a more physiological hormonal contraception].
    Hamann B; Büchner C
    Zentralbl Gynakol; 1976; 98(23):1445-9. PubMed ID: 65068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum immunoglobulins and C-reactive protein following oral administration of ovulation inhibitors].
    Gay S; Seidenschnur G; Geiler G
    Dtsch Gesundheitsw; 1972 Jan; 27(1):32-4. PubMed ID: 4111064
    [No Abstract]   [Full Text] [Related]  

  • 23. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive.
    Christie GA
    Med J Aust; 1969 Jul; 2(4):185-9. PubMed ID: 4184973
    [No Abstract]   [Full Text] [Related]  

  • 24. [Early tubal abortion during oral contraception].
    Köpernik H; Timmel H
    Zentralbl Gynakol; 1972 Sep; 94(38):1248-52. PubMed ID: 4118175
    [No Abstract]   [Full Text] [Related]  

  • 25. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
    Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
    Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-dose continuous chlormadinone acetate as an oral contraceptive. A clinical trial.
    Howard G; Blair M; Elstein M; Morris NF
    Lancet; 1969 Jul; 2(7610):24-6. PubMed ID: 4182794
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical application of the mixture of mestranol and chlormadinone for functional anomaly of the ovary].
    Kobayshi T; Amenomori Y; Nagai N; Egusa M; Ichikawa T
    Saishin Igaku; 1966 Sep; 21(9):2089-94. PubMed ID: 4166819
    [No Abstract]   [Full Text] [Related]  

  • 28. [Has low-dosage therapy with the oral contraceptive Ovosiston any effect on glucose tolerance and liver function?].
    Heller H; Canzler E
    Z Gesamte Inn Med; 1970 Oct; 25(20):936-40. PubMed ID: 4106958
    [No Abstract]   [Full Text] [Related]  

  • 29. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
    Matthews AE; Clarke JE
    J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921
    [No Abstract]   [Full Text] [Related]  

  • 30. [Problems of the statistical evaluation of clinical studies on oral contraceptives].
    Richter RH; Angst-Horridge A; Arnold M; Mall-Haefeli M; Roth F; Streit-Pfenniger M; Wyss H
    Arch Gynakol; 1969; 207(1):28-30. PubMed ID: 4184750
    [No Abstract]   [Full Text] [Related]  

  • 31. [Testing of an anti-conception drug: pure gestagen (chlormadinone acetate) in continually low dose].
    Jeppsson S; Kullander S
    Lakartidningen; 1969 Sep; 66(39):3949-55. PubMed ID: 4192490
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of the oral contraceptive Ovosiston on the composition of human milk.
    Ramadan MA; Salah MM; Eid SZ; Sammour MB
    J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liver function studies under the effect of 4 sequential hormonal contraceptives].
    Brügmann E; Göretzlehner G; Klie E; Schwager A; Maass M
    Z Gesamte Inn Med; 1978 Nov; 33(22):826-9. PubMed ID: 85373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of the hormonal effect of ovosiston in various dosages].
    Kühndel K; Ebeling K; Rothe K
    Z Arztl Fortbild (Jena); 1971 Jan; 65(2):79-84. PubMed ID: 4104626
    [No Abstract]   [Full Text] [Related]  

  • 35. [Two-stage therapy as a method of hormonal contraception in comparison with compound preparations].
    Rothe K
    Z Gesamte Hyg; 1970 Apr; 16(4):289-90. PubMed ID: 4108397
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
    de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
    Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
    [No Abstract]   [Full Text] [Related]  

  • 37. [Steroid metabolism in primates. XVIII. Return to higher levels of 17-ketosteroid excretion in urine after ending a long-term treatment with mestranol/chlormadinone acetate in the baboon].
    Gontscharow NP; Woronzow WI; Schön R; Hobe G; Schubert K
    Endokrinologie; 1976 Jul; 67(3):362-4. PubMed ID: 61857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the two-phase treatment with mestranol-chlormadinone acetate in dysfunctional hemorrhages, functional sterility and dys-or hypogonadotropic amenorrheas].
    Göretzlehner G
    Dtsch Gesundheitsw; 1967 Jun; 22(24):1124-6. PubMed ID: 4176451
    [No Abstract]   [Full Text] [Related]  

  • 39. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan.
    Sawasaki C; Ashitaka Y
    J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084
    [No Abstract]   [Full Text] [Related]  

  • 40. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.